A GENETIC RESPONSE SCORE FOR HYDROCHLOROTHIAZIDE USE: INSIGHTS FROM GENOMICS AND METABOLOMICS INTEGRATION

Hydrochlorothiazide (HCTZ) is among the most commonly prescribed antihypertensives, yet <50% of HCTZ treated patients achieve blood pressure (BP) control. Herein, we integrated metabolomic and genomic profiles of HCTZ treated patients to identify novel genetic markers associated with HCTZ BP resp...

詳細記述

保存先:
書誌詳細
出版年:Hypertension
主要な著者: Shahin, Mohamed H., Gong, Yan, McDonough, Caitrin W., Rotroff, Daniel M., Beitelshees, Amber L, Garrett, Timothy J., Gums, John G., Motsinger-Reif, Alison, Chapman, Arlene B., Turner, Stephen T., Boerwinkle, Eric, Frye, Reginald F., Fiehn, Oliver, Cooper-DeHoff, Rhonda M., Kaddurah-Daouk, Rima, Johnson, Julie A.
フォーマット: Artigo
言語:Inglês
出版事項: 2016
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4982802/
https://ncbi.nlm.nih.gov/pubmed/27381900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/HYPERTENSIONAHA.116.07328
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料